Loss in DXA-estimated total body lean mass but not fat mass predicts incident major osteoporotic fracture and hip fracture independently from FRAX: a registry-based cohort study.


Journal

Archives of osteoporosis
ISSN: 1862-3514
Titre abrégé: Arch Osteoporos
Pays: England
ID NLM: 101318988

Informations de publication

Date de publication:
25 06 2020
Historique:
received: 24 03 2020
accepted: 19 06 2020
entrez: 27 6 2020
pubmed: 27 6 2020
medline: 1 12 2020
Statut: epublish

Résumé

During median follow-up 6.0 years in 9622 individuals, prior loss in estimated total body lean mass (TBLM), but not total body fat mass loss (TBFM), was associated with increased fracture risk, particularly for hip fracture. Weight loss, and especially muscle loss, adversely affects skeletal health. The FRAX® tool considers baseline body mass index, but not body composition nor changes in its components over time. Our aim was to compare the independent associations between prior loss in DXA-estimated TBLM and TBFM and subsequent fracture risk. We identified women and men age 40 years or older with two DXA assessments at least 1 year apart (median interval 3.3 years). TBLM and TBFM were estimated from weight, sex, and DXA of the spine and hip. Incident fractures and deaths were ascertained from linked population-based health service data after the date of the second DXA. Hazard ratios (HRs) from Cox regression models were used to study time to fracture from prior loss in TBLM and TBFM adjusted for FRAX-related covariates. The study population consisted of 9622 individuals (mean age 67 [SD 10] years, 95% female). We identified 692 subjects with incident major osteoporotic fracture [MOF] and 194 with hip fracture. Mean TBLM loss was significantly greater in those with incident MOF and hip fracture (P < 0.001) while TBFM loss was only significantly greater in those with incident hip fracture (P < 0.001). Each SD greater TBLM loss was associated with 10-13% increased MOF risk and 29-38% increased hip fracture risk, adjusted for TBFM loss and other covariates. Prior TBFM loss was not associated with fractures when adjusted for TBLM loss. Prior loss in total body lean mass, but not in fat mass, is associated with increased fracture risk, particularly hip fracture, independent of other risk factors. This is consistent with the hypothesis that muscle loss (sarcopenia) adversely impacts skeletal health and fracture risk.

Identifiants

pubmed: 32588147
doi: 10.1007/s11657-020-00773-w
pii: 10.1007/s11657-020-00773-w
pmc: PMC7115892
mid: EMS86779
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

96

Subventions

Organisme : Versus Arthritis
ID : 17702
Pays : United Kingdom
Organisme : Versus Arthritis
ID : 21231
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12011/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/P020941/1
Pays : United Kingdom

Références

Osteoporos Int. 2013 Feb;24(2):681-8
pubmed: 22736068
J Am Geriatr Soc. 2003 Dec;51(12):1740-7
pubmed: 14687352
J Bone Miner Res. 2015 Dec;30(12):2168-78
pubmed: 26012544
J Clin Densitom. 2003 Fall;6(3):275-82
pubmed: 14514998
Bone. 2009 May;44(5):734-43
pubmed: 19195497
Obesity (Silver Spring). 2019 Nov;27(11):1839-1845
pubmed: 31486297
J Biomed (Syd). 2018;3:40-49
pubmed: 30505650
Arch Osteoporos. 2013;8:143
pubmed: 23740086
CMAJ. 2010 Nov 23;182(17):1864-73
pubmed: 20940232
Bone. 2017 Jan;94:108-113
pubmed: 27989649
J Nutr Health Aging. 2017;21(7):843-848
pubmed: 28717816
Osteoporos Int. 2020 Jun;31(6):1079-1087
pubmed: 32016485
J Clin Densitom. 2005 Spring;8(1):25-30
pubmed: 15722584
Calcif Tissue Int. 2018 Jul;103(1):16-23
pubmed: 29305636
Osteoporos Int. 2014 Oct;25(10):2359-81
pubmed: 25182228
Osteoporos Int. 2019 Mar;30(3):541-553
pubmed: 30610245
J Bone Miner Res. 2018 Jul;33(7):1209-1218
pubmed: 29502340
J Bone Miner Res. 2017 Nov;32(11):2278-2287
pubmed: 28678345
J Bone Miner Res. 2018 Dec;33(12):2150-2157
pubmed: 30011086
BMC Public Health. 2012 May 18;12:301
pubmed: 22537071
J Am Geriatr Soc. 2015 Nov;63(11):2247-59
pubmed: 26502831
J Bone Miner Res. 2018 Sep;33(9):1622-1629
pubmed: 29701911
J Bone Miner Res. 2016 Jul;31(7):1466-72
pubmed: 26861139
Osteoporos Int. 2018 Jun;29(6):1253-1262
pubmed: 29500527
J Am Geriatr Soc. 2011 Feb;59(2):233-40
pubmed: 21288234
Osteoporos Int. 2011 Mar;22(3):817-27
pubmed: 21161509
Osteoporos Int. 2018 Mar;29(3):675-683
pubmed: 29198074
J Bone Miner Res. 2014 Nov;29(11):2511-9
pubmed: 24825359
Osteoporos Int. 1998;8(5):468-89
pubmed: 9850356
BMC Geriatr. 2019 Mar 22;19(1):90
pubmed: 30902044

Auteurs

William D Leslie (WD)

Rady Faculty of Health Sciences, University of Manitoba, C5121-409 Tache Avenue, Winnipeg, Manitoba, R2H 2A6, Canada. bleslie@sbgh.mb.ca.

John T Schousboe (JT)

Park Nicollet Clinic & HealthPartners Institute, Saint Louis Park, Minneapolis, MN, USA.
University of Minnesota, Minneapolis, MN, USA.

Suzanne N Morin (SN)

McGill University, Montreal, Canada.

Patrick Martineau (P)

Rady Faculty of Health Sciences, University of Manitoba, C5121-409 Tache Avenue, Winnipeg, Manitoba, R2H 2A6, Canada.

Lisa M Lix (LM)

Rady Faculty of Health Sciences, University of Manitoba, C5121-409 Tache Avenue, Winnipeg, Manitoba, R2H 2A6, Canada.

Helena Johansson (H)

University of Sheffield Medical School, Centre for Metabolic Bone Diseases, Sheffield, UK.
Mary McKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia.

Eugene V McCloskey (EV)

University of Sheffield Medical School, Centre for Metabolic Bone Diseases, Sheffield, UK.
Centre for Integrated Research in Musculoskeletal Ageing (CIMA), Mellanby Centre for Bone Research, University of Sheffield, Sheffield, UK.

Nicholas C Harvey (NC)

MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK.
NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.

John A Kanis (JA)

University of Sheffield Medical School, Centre for Metabolic Bone Diseases, Sheffield, UK.
Mary McKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH